The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Open accessAbstract
Background: Key knowledge gaps remain in the understanding of viral dynamics and immune response of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Methods: We evaluated these characteristics and established their association with clinical severity in a prospective observational cohort study of 100 patients with PCR-confirmed SARS-CoV-2 infection (mean age, 46 years; 56% male; 38% with comorbidities). Respiratory samples (n = 74) were collected for viral culture, serum samples for measurement of IgM/IgG levels (n = 30), and plasma samples for levels of inflammatory cytokines and chemokines (n = 81). Disease severity was correlated with results from viral culture, serologic testing, and immune markers. Results: Fifty-seven (57%) patients developed viral pneumonia, of whom 20 (20%) required supplemental oxygen, including 12 (12%) with invasive mechanical ventilation. Viral culture from respiratory samples was positive for 19 of 74 patients (26%). No virus was isolated when the PCR cycle threshold (Ct) value was >30 or >14 days after symptom onset. Seroconversion occurred at a median (IQR) of 12.5 (9–18) days for IgM and 15.0 (12–20) days for IgG; 54/62 patients (87.1%) sampled at day 14 or later seroconverted. Severe infections were associated with earlier seroconversion and higher peak IgM and IgG levels. Levels of IP-10, HGF, IL-6, MCP-1, MIP-1α, IL-12p70, IL-18, VEGF-A, PDGF-BB, and IL-1RA significantly correlated with disease severity. Conclusions: We found virus viability was associated with lower PCR Ct value in early illness. A stronger antibody response was associated with disease severity. The overactive proinflammatory immune signatures offer targets for host-directed immunotherapy, which should be evaluated in randomized controlled trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Self-citationAntibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citationAntibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
COVID-19: combining antiviral and anti-inflammatory treatments
Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117
van Kampen, J. J. A., van de Vijver, D. A. M. C., Fraaij, P. L. A., Haagmans, B. L., Lamers, M. M., Okba, N., van den Akker, J. P. C., Endeman, H., Gommers, D. A. M. P. J., Cornelissen, J. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20568-4 · Cited by 838
Cited by
MCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
Alhazzani, W., Evans, L., Alshamsi, F., Møller, M. H., Ostermann, M., Prescott, H. C., Arabi, Y. M., Loeb, M., Ng Gong, M., Fan, E., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004899 · Cited by 417
Ong, S. W. X., Chiew, C. J., Ang, L. W., Mak, T. M., Cui, L., Toh, M. P. H. S., Lim, Y. D., Lee, P. H., Lee, T. H., Chia, P. Y., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab721 · Cited by 384
Self-citationChia, W. N., Zhu, F., Ong, S. W. X., Young, B. E., Fong, S.-W., Le Bert, N., Tan, C. W., Tiu, C., Zhang, J., Tan, S. Y., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00025-2 · Cited by 360
Self-citationDatta, S. D., Talwar, A., & Lee, J. T. (2020) · JAMA · doi:10.1001/jama.2020.22717 · Cited by 316
Metadata
- Authors
- Young, B. E., Ong, S. W. X., Ng, L. F. P., Anderson, D. E., Chia, W. N., Chia, P. Y., Ang, L. W., Mak, T.-M., Kalimuddin, S., Chai, L. Y. A., Pada, S., Tan, S. Y., Sun, L., Parthasarathy, P., Fong, S.-W., Chan, Y.-H., Tan, C. W., Lee, B., Rötzschke, O., Ding, Y., Tambyah, P., Low, J. G. H., Cui, L., Barkham, T., Lin, R. T. P., Leo, Y.-S., Renia, L., Wang, L.-F., Lye, D. C., Singapore 2019 Novel Coronavirus Outbreak Research Team, Lim, P. L., Peng Ang, B. S., Lee, C. C., U Lee, L. S., Ling, L. M., Ng, O. T., Chan, M., Marimuthu, K., Vasoo, S., Wong, C. S., Lee, T. H., Sadarangani, S., Lin, R. J., Sadasiv, M. S., Ling Ng, D. H., Choy, C. Y., En Tan, G. S., Tan, Y. K., Sutjipto, S., Lee, P. H., Tay, J. Y., Yeo, T. W., Khoo, B. Y., Tay, W. C., Ng, G., Mah, Y. Y., Tan, W., De, P. P., Pooja, R., Chia, J. W. Z., Constance Chen, Y. Y., Mendis, S., Toh, B. K., Choon Fong, R. K., Lin Oh, H. M., Fong Chien, J. M., Shafi, H., Cheong, H. Y., Tan, T. Y., Tan, T. T., Tan, B. H., Wijaya, L., Venkatachalam, I., Chua, Y. Y., Zhi Cherng, B. P., Zi Chan, Y. F., Wong, H. M., Thien, S. Y., Meng Goh, K. C., Ling Tan, S. Y., Ean Oon, L. L., Chan, K. S., Lin, L., Gin Chan, D. S., Ooi, S. T., Narayana, D. R., Somani, J., Ling Oon, J. E., Yan, G. Z., Allen, D. M., Jureen, R., Yan, B., Foo, R., Kang, A., Sivalingam, V., How, W., Fernandez, N. L., Yeo, N. K.-W., Chee, R. S.-L., & Amrun, S. N.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-28
- Volume
- 73
- Issue
- 9
- Pages
- e2932-e2942
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3081052435
- Cited by
- 199
- References
- 9
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. https://app.cochat.ai/papers/10.1093/cid/ciaa1280
- The paper
- Young, B. E., Ong, S. W. X., Ng, L. F. P., Anderson, D. E., Chia, W. N., Chia, P. Y., Ang, L. W., Mak, T.-M., Kalimuddin, S., Chai, L. Y. A., Pada, S., Tan, S. Y., Sun, L., Parthasarathy, P., Fong, S.-W., Chan, Y.-H., Tan, C. W., Lee, B., Rötzschke, O., . . . Amrun, S. N. (2021). Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa1280
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.